Kissova M, Martinez Segarra J, Iveland TS, Vestvik M, Ravlo E, Wang W, Hagen L, Liabakk NB, Camara-Quilez M, Arano Barenys M, Solheim O, Hoff BH, Sundby E, Bjørås M, Slupphaug G, Visnes T, Brambilla A (2025)
RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells
Sci Rep, 15 (1), 41486
DOI 10.1038/s41598-025-25298-5, PubMed 41285884

Zhou W, Martinez-Garcia E, Sarnow K, Kanli G, Nazarov PV, Li Y, Schwab S, Meiser J, Jaeger C, Mieczkowski J, Misztak A, Thorsen FA, Grützmann K, Mihaljevic B, van Loon B, Hossain JA, Zhang Y, Xue Z, Li W, Moreino SS, Golebiewska A, Niclou SP, Bjørås M, Tardito S, Joesph JV et al. (2025)
Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy
Neuro Oncol (in press)
DOI 10.1093/neuonc/noaf271, PubMed 41284925

Ravlo E, Ianevski A, Skipperstøen MN, Lysvand H, Schjølberg JO, Solheim O, Wang W, Kissova M, Vestvik M, Vapalahti O, Smura T, Vauhkonen H, Oksenych V, Weber F, Strand M, Evander M, Malmring JF, Afset JE, Bjørås M, Kainov DE (2025)
JAK inhibitors remove innate immune barriers facilitating viral propagation
NAR Mol Med, 2 (2), ugaf017
DOI 10.1093/narmme/ugaf017, PubMed 41255708